Abstract Policies

37th Annual Meeting Abstract Policies

For more information, please download the 2022 Regular and Late-Breaking Abstract Reference Guide.
Below are the policies of the SITC abstract submission process. By submitting an abstract, you are agreeing to abide by these policies.

Abstract Embargo and Release Information Policy

Regular and Late-Breaking Abstract Titles

Titles for regular abstracts will be available  Oct. 5, 2022, and titles for late-breaking abstracts will be available at  Nov. 2, 2022, on the SITC Annual Meeting website and app. Once abstract titles are listed on the website, press releases can be issued with the titles and logistical information.

Regular and Late-Breaking Abstract Content

Full regular and late-breaking abstract content will be embargoed until Nov. 7, 2022 at 8 a.m. EST. This includes content within the original abstract submitted, additional data that was available on a poster of the abstract and/or any updated and/or any new data that will be available in any oral presentations in SITC's Annual Meeting.

Poster Presentation Data Embargo

(Posters only): Any additional data that will be available on a poster that is beyond what was submitted in the abstract is embargoed until Nov. 10, 2022 at 9 a.m. EST. This embargo applies to poster-only presentations.

Oral Presentation Data Embargo

Any updated and/or new data that will be available in an oral presentation is embargoed until the date and time of the presentation. If the oral presenter is also creating a poster which includes updated and/or new data, the poster shares the same Oral Presentation Embargo date, not the poster embargo date specified above. This embargo applies to oral abstract presentations.

Copyright Policy

Parameters for requesting permission to use abstracts and articles published in JITC are detailed in BMJ’s copyright policy. For detailed information on how to cite, reference, give attribution to, use, reuse, etc. regarding an article or an abstract published in JITC, please consult the publisher, BMJ. You must adhere to the rules in accordance with the type of license granted to BMJ.

Press Release Policy

Any planned press releases and media alerts must have been reviewed and approved in advance by SITC Communications staff. Please provide a minimum for two business days for review. Drafts should be emailed to communications@sitcancer.org.


  • Before 8 a.m. EST on Nov. 7, 2022: Press releases should be issued with only logistical information (abstract title, author, poster number, and presentation date and time) about an abstract/poster/oral presentation

  • After 8 a.m. EST on Nov. 7, 2022: Press releases should be issued with information about the content within the original abstract submitted. Additional data that will be available, such as on a poster of the abstract and/or any updated and/or new data that will be available in oral presentation at SITC’s Annual Meeting, should follow the above embargo policies.

Withdrawal & Editing Policy

The deadline for regular abstract and Young Investigator Award abstract withdrawals, including presenter changes, is Sept. 1, 2022. The deadline for late-breaking abstract withdrawals, including presenter changes, is Sept. 23, 2022. These deadlines are set in place because the abstract information is pulled for publication immediately following these dates and cannot be edited after that. If you would like to withdraw your abstract between the submission deadline and this date, you must submit your request in writing to education@sitcancer.org. Upon receipt of your request SITC will make the withdrawal and send a confirmation once the withdrawal has been completed.

SITC Privacy Policy

Please see the SITC Privacy Policy regarding providing your information on SITC platforms and our service providers, including the Abstract Management System provided by Planstone.

Encore Presentation Policy

Any abstract that has been previously accepted and/or published (by any meeting or publisher) must contain substantial new data in order to be considered. Contact education@sitcancer.org with any questions pertaining to substantial new data.

941.jpg
941.jpg
941.jpg